Cargando…

HIV treatment for prevention

"No virus, no transmission." Studies have repeatedly shown that viral load (the quantity of virus present in blood and sexual secretions) is the strongest predictor of HIV transmission during unprotected sex or transmission from infected mother to child. Effective treatment lowers viral lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrosioni, Juan, Calmy, Alexandra, Hirschel, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123616/ https://www.ncbi.nlm.nih.gov/pubmed/21612619 http://dx.doi.org/10.1186/1758-2652-14-28

Ejemplares similares

Blinded by Zika? A missed HIV diagnosis that resulted in optic neuropathy and blindness: a case report
por: Hirschel, Tiffany, et al.
Publicado: (2017)

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
por: Díaz, Natalia A., et al.
Publicado: (2021)

Driving a decade of change: HIV/AIDS, patents and access to medicines for all
por: Hoen, Ellen 't, et al.
Publicado: (2011)

Higher Memory Responses in HIV-Infected and Kidney Transplanted Patients than in Healthy Subjects following Priming with the Pandemic Vaccine
por: Siegrist, Claire-Anne, et al.
Publicado: (2012)

Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field
por: Granziera, Cristina, et al.
Publicado: (2013)

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review
por: Wagner, N., et al.
Publicado: (2015)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy
por: Calmy, Alexandra, et al.
Publicado: (2018)

HIV Treatment as Prevention: Natural Experiments Highlight Limits of Antiretroviral Treatment as HIV Prevention
por: Wilson, David P.
Publicado: (2012)

Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)
por: Srasuebkul, Preeyaporn, et al.
Publicado: (2007)

HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention
por: Boily, Marie-Claude, et al.
Publicado: (2012)

HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes
por: Delva, Wim, et al.
Publicado: (2012)

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial
por: Maitre, Thomas, et al.
Publicado: (2022)

Overview of SARS-CoV-2 infection in adults living with HIV
por: Ambrosioni, Juan, et al.
Publicado: (2021)

Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report
por: Emonet, Stephane, et al.
Publicado: (2010)

HIV Treatment as Prevention: Issues in Economic Evaluation
por: Bärnighausen, Till, et al.
Publicado: (2012)

Nanosystems Applied to HIV Infection: Prevention and Treatments
por: Macchione, Micaela A., et al.
Publicado: (2020)

Treatment and Prevention of Histoplasmosis in Adults Living with HIV
por: McKinsey, David S.
Publicado: (2021)

HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
por: Cohen, Myron S., et al.
Publicado: (2012)

Turnover of CD4(+) and CD8(+) T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
por: Sachsenberg, Nicolas, et al.
Publicado: (1998)

Corrigendum to “Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review” [New Microbes New Infect] 6 (2015) 1–4]
por: Wagner, N., et al.
Publicado: (2015)

COVID-19 in patients with HIV: clinical case series
por: Blanco, Jose L, et al.
Publicado: (2020)

Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literature
por: Sculier, Delphine, et al.
Publicado: (2014)

HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups
por: Nomah, Daniel K, et al.
Publicado: (2021)

HIV Treatment as Prevention: The Utility and Limitations of Ecological Observation
por: Smith, M. Kumi, et al.
Publicado: (2012)

Antibody-mediated prevention and treatment of HIV-1 infection
por: Gruell, Henning, et al.
Publicado: (2018)

HIV/AIDS: Current Updates on the Disease, Treatment and Prevention
por: Gupta, Praveen Kumar, et al.
Publicado: (2021)

Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
por: Carballo, David, et al.
Publicado: (2015)

Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
por: Ford, Nathan, et al.
Publicado: (2011)

Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study
por: Borghi, Claudio, et al.
Publicado: (2018)

HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation
por: Delva, Wim, et al.
Publicado: (2012)

Harnessing nanostructured systems for improved treatment and prevention of HIV disease
por: Monroe, Maya, et al.
Publicado: (2018)

Prophylaxis for COVID-19: a systematic review
por: Smit, Mikaela, et al.
Publicado: (2021)

The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
por: Surial, Bernard, et al.
Publicado: (2021)

Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approach
por: Sculier, Delphine, et al.
Publicado: (2014)

Proving the Mode of Action of Phytotoxic Phytochemicals
por: Duke, Stephen O., et al.
Publicado: (2020)

How the COVID-19 Pandemic Alters the Landscapes of the HIV and Tuberculosis Epidemics in South Africa: A Case Study and Future Directions
por: Eike, Daniel, et al.
Publicado: (2022)

Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
por: Lee, Janice Soo Fern, et al.
Publicado: (2012)

HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sknhmuokt6m700ik5nnc65hoop